In cortical neurons HDAC3 activity suppresses RD4-dependent SMRT export

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Soriano, Francesc X ^a,b   Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APICIDIN; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TRICHOSTATIN A; VALPROIC ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DEACETYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; NONHUMAN; POINT MUTATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; ACETYLATION; ACTIVE TRANSPORT; ANIMAL; BRAIN CORTEX; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; NERVE CELL; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT; SYNAPSE;

RATTUS;

ACETYLATION; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CEREBRAL CORTEX; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; NEURONS; NUCLEAR RECEPTOR CO-REPRESSOR 2; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE DELETION; SYNAPSES;

EID: 79958245644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021056     Document Type: Article

References (50)

1. Jepsen K, Rosenfeld MG, (2002) Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115: 689-698.
2. Privalsky ML, (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66: 315-360.
3. Perissi V, Jepsen K, Glass CK, Rosenfeld MG, (2010) Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet 11: 109-123.
4. Gregoire S, Xiao L, Nie J, Zhang X, Xu M, et al. (2007) Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol 27: 1280-1295.
5. Ki SH, Cho IJ, Choi DW, Kim SG, (2005) Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol Cell Biol 25: 4150-4165.
6. Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, et al. (2000) A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 14: 1048-1057.
7. Cheng X, Kao HY, (2009) G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation. J Biol Chem 284: 36395-36404.
8. Li J, Wang J, Nawaz Z, Liu JM, Qin J, et al. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19: 4342-4350.
9. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, et al. (2003) Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. Embo J 22: 1336-1346.
10. Zhang J, Kalkum M, Chait BT, Roeder RG, (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9: 611-623.
11. Kao HY, Downes M, Ordentlich P, Evans RM, (2000) Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev 14: 55-66.
12. Huang EY, Zhang J, Miska EA, Guenther MG, Kouzarides T, et al. (2000) Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev 14: 45-54.
13. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, et al. (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9: 45-57.
14. Guenther MG, Barak O, Lazar MA, (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101.
15. Jepsen K, Solum D, Zhou T, McEvilly RJ, Kim HJ, et al. (2007) SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450: 415-419.
16. Soriano FX, Leveille F, Papadia S, Bell KF, Puddifoot C, et al. (2010) Neuronal activity controls the antagonistic balance between PGC-1α and SMRT in regulating antioxidant defences. Antioxid Redox Signal 14: 1425-1436.
17. Lee JW, Lee YC, Na SY, Jung DJ, Lee SK, (2001) Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol Life Sci 58: 289-297.
18. Hong SH, Privalsky ML, (2000) The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export. Mol Cell Biol 20: 6612-6625.
19. Zhou Y, Gross W, Hong SH, Privalsky ML, (2001) The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II). Mol Cell Biochem 220: 1-13.
20. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG, (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116: 511-526.
21. Stanya KJ, Liu Y, Means AR, Kao HY, (2008) Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. J Cell Biol 183: 49-61.
22. Wu X, Li H, Park EJ, Chen JD, (2001) SMRTE inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains. J Biol Chem 276: 24177-24185.
23. Downes M, Ordentlich P, Kao HY, Alvarez JG, Evans RM, (2000) Identification of a nuclear domain with deacetylase activity. Proc Natl Acad Sci U S A 97: 10330-10335.
24. Hoberg JE, Yeung F, Mayo MW, (2004) SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell 16: 245-255.
25. Jonas BA, Varlakhanova N, Hayakawa F, Goodson M, Privalsky ML, (2007) Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol Endocrinol 21: 1924-1939.
26. Mckenzie GJ, Stephenson P, Ward G, Papadia S, Bading H, et al. (2005) Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J Neurochem 93: 171-185.
27. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT, (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32: 591-601.
28. Sleiman SF, Basso M, Mahishi L, Kozikowski AP, Donohoe ME, et al. (2009) Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs 18: 573-584.
29. Hardingham GE, Arnold FJ, Bading H, (2001) Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 4: 261-267.
30. Martel M, Wyllie DJ, Hardingham GE, (2009) In developing hippocampal neurons, NR2B-containing NMDA receptors can mediate signalling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158: 334-343.
31. Papadia S, Stevenson P, Hardingham NR, Bading H, Hardingham GE, (2005) Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci 25: 4279-4287.
32. Bading H, Ginty DD, Greenberg ME, (1993) Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260: 181-186.
33. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, et al. (2004) Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel 17: 527-536.
34. Leveille F, Papadia S, Fricker M, Bell KF, Soriano FX, et al. (2010) Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci 30: 2623-2635.
35. Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK, (2006) Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol Cell Endocrinol 246: 147-156.
36. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, et al. (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409: 581-589.
37. Karagianni P, Wong J, (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26: 5439-5449.
38. Varlakhanova N, Hahm JB, Privalsky ML, (2010) Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation. Mol Cell Endocrinol.
39. Spange S, Wagner T, Heinzel T, Krämer OH, (2009) Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The International Journal of Biochemistry & Cell Biology 41: 185-198.
40. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, et al. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325: 834-840.
41. Kawaguchi Y, Ito A, Appella E, Yao TP, (2006) Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281: 1394-1400.
42. Jing E, Gesta S, Kahn CR, (2007) SIRT2 Regulates Adipocyte Differentiation through FoxO1 Acetylation/Deacetylation. Cell Metabolism 6: 105-114.
43. van der Horst A, Burgering BMT, (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440-450.
44. Shimazu T, Horinouchi S, Yoshida M, (2007) Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3′-end processing. J Biol Chem 282: 4470-4478.
45. Baltus GA, Kowalski MP, Zhai H, Tutter AV, Quinn D, et al. (2009) Acetylation of sox2 induces its nuclear export in embryonic stem cells. Stem Cells 27: 2175-2184.
46. Thevenet L, Mejean C, Moniot B, Bonneaud N, Galeotti N, et al. (2004) Regulation of human SRY subcellular distribution by its acetylation/deacetylation. EMBO J 23: 3336-3345.
47. Ishizuka T, Lazar MA, (2005) The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor. Mol Endocrinol 19: 1443-1451.
48. Xu WS, Parmigiani RB, Marks PA, (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26: 5541-5552.
49. Langley B, D'Annibale MA, Suh K, Ayoub I, Tolhurst A, et al. (2008) Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection. J Neurosci 28: 163-176.
50. Bruserud O, Stapnes C, Ersvaer E, Gjertsen BT, Ryningen A, (2007) Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell. Curr Pharm Biotechnol 8: 388-400.